Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, Harrison SM, Group CSVIW (2018) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat 39:1517–1524. https://doi.org/10.1002/humu.23626

Article  PubMed  PubMed Central  Google Scholar 

All of Us Research Program I, Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, Jenkins G, Dishman E (2019) The “All of Us” research program. N Engl J Med 381:668–676. https://doi.org/10.1056/NEJMsr1809937

Article  Google Scholar 

Biesecker LG (2016) Overcalling secondary findings. Genet Med 18:416–416. https://doi.org/10.1038/gim.2016.19

Article  PubMed  Google Scholar 

Biesecker LG, Harrison SM (2018) The ACMG/AMP reputable source criteria for the interpretation of sequence variants. Genet Med 20:1687–1688. https://doi.org/10.1038/gim.2018.42

Article  PubMed  PubMed Central  Google Scholar 

Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD, Kanavy DM, Luo X, McNulty SM, Starita LM (2020) Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med 12:1–12. https://doi.org/10.1186/s13073-019-0690-2

Article  Google Scholar 

Chan SH, Bylstra Y, Teo JX, Kuan JL, Bertin N, Gonzalez-Porta M, Hebrard M, Tirado-Magallanes R, Tan JHJ, Jeyakani J (2022) Analysis of clinically relevant variants from ancestrally diverse Asian genomes. Nat Commun 13:1–15. https://doi.org/10.1038/s41467-022-34116-9

Article  CAS  Google Scholar 

Chetruengchai W, Shotelersuk V (2022) Actionable secondary findings in the 73 ACMG-recommended genes in 1559 Thai exomes. J Hum Genet 67:137–142. https://doi.org/10.1038/s10038-022-01037-w

Article  CAS  PubMed  Google Scholar 

Choe EJ, Choi JW, Kang M, Lee YK, Jeon HH, Park BK, Won SY, Cho YS, Seo JH, Lee CK (2020) A population-based epidemiology of Wilson’s disease in South Korea between 2010 and 2016. Sci Rep 10:1–10. https://doi.org/10.1038/s41598-020-70976-1

Article  CAS  Google Scholar 

Elfatih A, Mifsud B, Syed N, Badii R, Mbarek H, Abbaszadeh F, Consortium QGPR, Estivill X, Management QGP, Ismail S (2021a) Actionable genomic variants in 6045 participants from the Qatar Genome Program. Hum Mutat 42:1584–1601. https://doi.org/10.1002/humu.24278

Article  CAS  Google Scholar 

Elfatih A, Mohammed I, Abdelrahman D, Mifsud B (2021b) Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review. Physiol Genom 53:373–384. https://doi.org/10.1152/physiolgenomics.00025.2021

Article  CAS  Google Scholar 

Forrest IS, Chaudhary K, Vy HMT, Petrazzini BO, Bafna S, Jordan DM, Rocheleau G, Loos RJ, Nadkarni GN, Cho JH (2022) Population-based penetrance of deleterious clinical variants. JAMA 327:350–359. https://doi.org/10.1001/jama.2021.23686

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghosh R, Harrison SM, Rehm HL, Plon SE, Biesecker LG, Group CSVIW (2018) Updated recommendation for the benign stand-alone ACMG/AMP criterion. Hum Mutat 39:1525–1530. https://doi.org/10.1002/humu.23642

Article  PubMed  PubMed Central  Google Scholar 

Gordon AS, Zouk H, Venner E, Eng CM, Funke BH, Amendola LM, Carrell DS, Chisholm RL, Chung WK, Denny JC (2020) Frequency of genomic secondary findings among 21,915 eMERGE network participants. Genet Med 22:1470–1477. https://doi.org/10.1038/s41436-020-0810-9

Article  PubMed Central  Google Scholar 

Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O’Daniel JM, Ormond KE (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565–574. https://doi.org/10.1038/gim.2013.73

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haggerty CM, Damrauer SM, Levin MG, Birtwell D, Carey DJ, Golden AM, Hartzel DN, Hu Y, Judy R, Kelly MA (2019) Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation 140:42–54. https://doi.org/10.1161/CIRCULATIONAHA.119.039573

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horiuchi Y, Matsubayashi H, Kiyozumi Y, Nishimura S, Higashigawa S, Kado N, Nagashima T, Mizuguchi M, Ohnami S, Arai M (2021) Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients. Hum Genet 140:321–331. https://doi.org/10.1007/s00439-020-02207-6

Article  CAS  PubMed  Google Scholar 

Huang Y, Liu B, Shi J, Zhao S, Xu K, Sun L, Chen N, Tian W, Zhang J, Wu N (2022) Landscape of secondary findings in Chinese population: a practice of ACMG SF v3.0 list. J Personal Med 12:1503. https://doi.org/10.3390/jpm12091503

Article  Google Scholar 

Jang M, Lee S-H, Kim N, Ki C-S (2015) Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes. Genet Med 17:1007–1011. https://doi.org/10.1038/gim.2015.26

Article  CAS  PubMed  Google Scholar 

Jukarainen S, Kiiskinen T, Kuitunen S, Havulinna AS, Karjalainen J, Cordioli M, Ramo JT, Mars N, FinnGen SKE, Ollila HM, Pirinen M, Ganna A (2022) Genetic risk factors have a substantial impact on healthy life years. Nat Med 28:1893–1901. https://doi.org/10.1038/s41591-022-01957-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim Y, Han B-G, Group K (2017) Cohort profile: the Korean genome and epidemiology study (KoGES) consortium. Int J Epidemiol 46:e20–e20. https://doi.org/10.1093/ije/dyv316

Article  PubMed  Google Scholar 

KISTI (2021) The National Project of Bio Big Data research portal. https://www.cirn.re.kr/index. Accessed 1 Dec 2022

Kwak SH, Chae J, Choi S, Kim MJ, Choi M, Chae J-H, Cho E-h, Jang SS, Kim J-I, Park KS (2017) Findings of a 1303 Korean whole-exome sequencing study. Exp Mol Med 49:e356–e356. https://doi.org/10.1038/emm.2017.142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landry LG, Ali N, Williams DR, Rehm HL, Bonham VL (2018) Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice. Health Aff 37:780–785. https://doi.org/10.1377/hlthaff.2017.1595

Article  Google Scholar 

Lawrence L, Sincan M, Markello T, Adams DR, Gill F, Godfrey R, Golas G, Groden C, Landis D, Nehrebecky M (2014) The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experience. Genet Med 16:741–750. https://doi.org/10.1038/gim.2014.29

Article  PubMed  PubMed Central  Google Scholar 

Li Q, Wang K (2017) InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Hum Genet 100:267–280. https://doi.org/10.1016/j.ajhg.2017.01.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, Flicek P, Cunningham F (2016) The ensembl variant effect predictor. Genome Biol 17:1–14. https://doi.org/10.1186/s13059-016-0974-4

Article  CAS  Google Scholar 

Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, Stewart DR, Amendola LM, Adelman K, Bale SJ (2021a) ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23:1381–1390. https://doi.org/10.1038/s41436-021-01172-3

Article  PubMed  Google Scholar 

Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, Chung WK, Gollob MH, Harrison SM, Herman GE (2021b) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 23:1391–1398. https://doi.org/10.1038/s41436-021-01171-4

Article  PubMed  Google Scholar 

Miller DT, Lee K, Abul-Husn NS, Amendola LM, Brothers K, Chung WK, Gollob MH, Gordon AS, Harrison SM, Hershberger RE (2022) ACMG SF v3. 1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med 24:1407–1414. https://doi.org/10.1016/j.gim.2022.04.006

Article  CAS  PubMed  Google Scholar 

Miner SA, Similuk M, Jamal L, Sapp J, Berkman BE (2022) Genomic tools for health: secondary findings as findings to be shared. Genet Med 24:2220–2227. https://doi.org/10.1016/j.gim.2022.07.015

Article  CAS  PubMed  Google Scholar 

Olfson E, Cottrell CE, Davidson NO, Gurnett CA, Heusel JW, Stitziel NO, Chen L-S, Hartz S, Nagarajan R, Saccone NL (2015) Identification of medically actionable secondary findings in the 1000 genomes. PLoS ONE 10:e0135193. https://doi.org/10.1371/journal.pone.0135193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan Z, Xu S (2020) Population genomics of East Asian ethnic groups. Hereditas 157:1–10. https://doi.org/10.1186/s41065-020-00162-w

Article  Google Scholar 

Pejaver V, Byrne AB, Feng B-J, Pagel KA, Mooney SD, Karchin R, O’Donnell-Luria A, Harrison SM, Tavtigian SV, Greenblatt MS (2022) Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am J Hum Genet 109:2163–2177. https://doi.org/10.1016/j.ajhg.2022.10.013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter DH, Maglott DR, Martin CL, Nussbaum RL (2015) ClinGen—the clinical genome resource. N Engl J Med 372:2235–2242. https://doi.org/10.1056/NEJMsr1406261

Article  CAS  PubMed  PubMed Central